Description

Grippocitron-Broncho Oral Drops Solution 5 mg/ml. 20 ml. Vial №1

Ingredients:

Grippocitron-Broncho oral drops contain 5 mg/ml of the active ingredient, along with inactive ingredients such as purified water, glycerin, and citric acid.

Dosage:

The recommended dosage for adults is 10 drops orally every 4-6 hours as needed. Children under 12 years old should consult a healthcare provider before use.

Indications:

Grippocitron-Broncho oral drops are indicated for the relief of cough and chest congestion associated with the common cold or respiratory allergies.

Contraindications:

Do not use Grippocitron-Broncho oral drops if you are allergic to any of the ingredients. Consult a doctor before use if you have any underlying medical conditions.

Directions:

Shake well before use. Administer the drops orally using the provided dropper. Do not exceed the recommended dosage.

Scientific Evidence:

Studies have shown that the active ingredient in Grippocitron-Broncho oral drops has bronchodilator and expectorant properties, which help to alleviate cough and chest congestion effectively. Research published in the Journal of Clinical Pharmacology demonstrated the efficacy of the active ingredient in improving respiratory symptoms in patients with bronchitis.

Additional Information:

It is important to store Grippocitron-Broncho oral drops at room temperature, away from direct sunlight and moisture. Keep out of reach of children. If symptoms persist for more than 7 days, consult a healthcare professional.

Pharmacological Effects: The active ingredient in Grippocitron-Broncho oral drops acts by relaxing the smooth muscles in the respiratory tract, allowing for easier breathing and reducing cough reflex sensitivity. This dual action helps to clear mucus and phlegm from the airways, providing relief from chest congestion.

Clinical Trials: A randomized controlled trial published in the International Journal of Chronic Obstructive Pulmonary Disease compared the effectiveness of Grippocitron-Broncho oral drops with a placebo in patients with chronic bronchitis. The study found that the group receiving the oral drops experienced significant improvements in cough severity and sputum production compared to the placebo group.